CMS Administrator Dr. Oz proposes deep cuts to the 340B drug program to lower Medicare costs. Learn how this affects ...

​A fight over an embattled drug discount program is intensifying on Capitol Hill, as lawmakers weigh competing proposals to reshape the program amid escalating tensions between hospitals and ...

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing policy debate.

The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved ...

The 340B Drug Pricing Program may be partly driving U.S. hospital consolidation and worsening affordability for patients, ...

The 340B program is criticized for generating revenue rather than solely aiding underinsured patients, impacting community providers and Medicare patients. Pharmaceutical companies face challenges ...

“When a program designed to deliver targeted assistance drives up system-wide costs, reform is no longer optional,” says health expert Sally Pipes. “It's necessary.” If a charity organization ...

The 340B fights of 2026 are being waged as disputes over fairness and intent. Underneath, they are disputes over data.

AHA responds to Information Collection Request about the Health Resources and Services Administration’s proposed 340B Rebate Model Program.

Even as they sparred on broader healthcare policy and funding topics fueling the ongoing government shutdown, senators of the Health, Education, Labor and Pensions Committee appear to agree that ...

Unexpected windfall or fragile safety net? Affluent communities or vulnerable poor? Welfare check or supplemental provider program? Making sense of the latest 340B program study published by the ...

The Government Accountability Office believes Congress should slash the financial incentives the government pays hospitals in the 340B drug program, it said in a new report, over concerns that ...